01-13-2022, 09:50 AM
(01-13-2022, 09:28 AM)ken-do-nim Wrote: I just checked in an old friend today, one LABU. Aka the world's worst triple leveraged fund. Back on Feb 8th of last year, it had reached a crescendo of $183 per share, and it has been steadily downhill ever since. Today, it sits at $25.50 (!). Overall performance is -78.25% in the past year.The nature of biotechs. Suffer for years and then launch for 6 months with eye popping gains. Time your entry correctly and you are a genius. The sector is scary enough without leveraging. Better done as a side game in a diversified health ETF where the managers just might have a better clue than I do (that isn't a high hurdle lol). The goals of the companies are admirable but they are about as volatile as a pot stock. Maybe worse.